Literature DB >> 17159542

Dopamine transporter density may be associated with the depressed affect in healthy subjects.

Andrew Newberg1, Jay Amsterdam, Justine Shults.   

Abstract

OBJECTIVES: Increased levels of dopamine transporter (DAT) binding have been reported in patients with major depression. We used the selective DAT radiopharmaceutical Tc-TRODAT-1 and SPECT brain imaging, to examine differences in DAT levels in healthy subjects with and without depressive affect.
METHODS: We compared striatal DAT binding affinity in 73 healthy subjects to their scores on the depressive symptoms subscale of the Profile of Mood States (POMS). Regions of interest in the basal ganglia of the brain were examined. Distribution volume ratios (DVRs) of Tc-TRODAT-1 binding affinity were calculated from the SPECT scan data, and comparisons among subjects with low and high depressive symptom ratings were calculated using unpaired t-tests and the Pearson correlation.
RESULTS: We observed a greater Tc-TRODAT-1 DVR in the right caudate of subjects with high POMS mood scores compared to subjects with low scores on depressive items on the POMS (2.99+/-0.35 and 2.79+/-0.35, respectively; P=0.009). There was also a weak, but significant correlation between higher Tc-TRODAT-1 DVRs in the right caudate and depressive symptoms scores (r=0.23, P=0.05).
CONCLUSIONS: These data suggest that Tc-TRODAT-1 binding affinity to DAT sites may be associated with depressive affect in healthy subjects. The finding also supports prior observations of greater Tc-TRODAT-1 DVRs in patients with major depressive episode.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17159542     DOI: 10.1097/MNM.0b013e328013dc9d

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

1.  Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Daniela Di Giuda; Giovanni Camardese; Anna Rita Bentivoglio; Fabrizio Cocciolillo; Arianna Guidubaldi; Lorella Pucci; Isabella Bruno; Luigi Janiri; Alessandro Giordano; Alfonso Fasano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-14       Impact factor: 9.236

2.  Dopamine polymorphisms and depressive symptoms predict foods intake. Results from a nationally representative sample.

Authors:  Tanya Agurs-Collins; Bernard F Fuemmeler
Journal:  Appetite       Date:  2011-06-06       Impact factor: 3.868

3.  Dopamine transporters govern diurnal variation in extracellular dopamine tone.

Authors:  Mark J Ferris; Rodrigo A España; Jason L Locke; Joanne K Konstantopoulos; Jamie H Rose; Rong Chen; Sara R Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

4.  Greater striatal dopamine transporter density may be associated with major depressive episode.

Authors:  Jay D Amsterdam; Andrew B Newberg; Irene Soeller; Justine Shults
Journal:  J Affect Disord       Date:  2012-04-04       Impact factor: 4.839

5.  Clinical comparison of 99mTc exametazime and 123I Ioflupane SPECT in patients with chronic mild traumatic brain injury.

Authors:  Andrew B Newberg; Mijail Serruya; Andrew Gepty; Charles Intenzo; Todd Lewis; Daniel Amen; David S Russell; Nancy Wintering
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

6.  1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous Neuroprotectant and MAO inhibitor with antidepressant-like properties in the rat.

Authors:  Agnieszka Wąsik; Edyta Możdżeń; Jerzy Michaluk; Irena Romańska; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2013-09-25       Impact factor: 3.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.